[Transcriptional regulation of the phase II drug detoxifying enzyme genes].
Itoh
K
K
Institute for Basic Medical Sciences, University of Tsukuba, Japan.
Yamamoto
M
M
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D002083:Butylated Hydroxyanisole / Q000494:pharmacology; D004790:Enzyme Induction / Q000187:drug effects / Q000235:genetics; D004798:Enzymes / Q000096:biosynthesis / Q000235:genetics*; D015971:Gene Expression Regulation, Enzymologic; D005982:Glutathione Transferase / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D008658:Inactivation, Metabolic; D011808:Quinone Reductases / Q000096:biosynthesis / Q000235:genetics; D014157:Transcription Factors / Q000502:physiology*; D014158:Transcription, Genetic
D000975:Antioxidants; D004798:Enzymes; D014157:Transcription Factors; D002083:Butylated Hydroxyanisole; C041831:NADH dehydrogenase (quinone); D011808:Quinone Reductases; D005982:Glutathione Transferase